
Trait Biosciences
Emerging cannabis biotechnology company.
Date | Investors | Amount | Round |
---|---|---|---|
investor investor | €0.0 | round | |
N/A | €0.0 Valuation: €0.0 | round | |
investor | €0.0 | round | |
investor investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
* | N/A | Early VC | |
Total Funding | 000k |
Related Content
Trait Biosciences is a biotechnology leader specializing in the hemp industry, focusing on cannabinoid production technologies. The company transforms scientific research into groundbreaking advances, particularly in the development of water-soluble CBD extracts. These extracts are designed to revolutionize the market for infused foods, beverages, cosmetics, and supplements. Trait Biosciences serves B2B clients, including manufacturers and brands looking to incorporate high-quality, purer, and safer hemp-derived products into their offerings. Operating primarily in the biotechnology and hemp markets, the company leverages its expertise in fermentation, metabolic engineering, bioinformatics, and computational biology to create innovative solutions. The business model revolves around licensing its proprietary technologies and selling its CBD extracts to various industries. Revenue is generated through these licensing agreements and direct sales of their products.
Keywords: biotechnology, hemp, cannabinoid, CBD, water-soluble, fermentation, metabolic engineering, bioinformatics, cosmetics, supplements.